Cipla gains on getting approval from USFDA for Valganciclovir Tablets

12 Nov 2018 Evaluate

Cipla is currently trading at Rs. 538.50, up by 11.70 points or 2.22% from its previous closing of Rs. 526.80 on the BSE.

The scrip opened at Rs. 528.65 and has touched a high and low of Rs. 538.60 and Rs. 528.65 respectively.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 678.00 on 19-Sep-2018 and a 52 week low of Rs. 508.10 on 22-May-2018.

Last one week high and low of the scrip stood at Rs. 616.60 and Rs. 524.10 respectively. The current market cap of the company is Rs. 42420.68 crore.

The promoters holding in the company stood at 36.74%, while Institutions and Non-Institutions held 39.45% and 23.81% respectively.

Cipla has received final approval for its Abbreviated New Drug Application (ANDA) for Valganciclovir Tablets 450mg from the United States Food and Drug Administration (USFDA).

The company’s Valganciclovir Tablets 450mg is AB-rated generic therapeutic equivalent version of Roche’s Valcyte. It is a deoxynucleoside analogue cytomegalovirus (CMV) DNA polymerase inhibitor indicated for use in the treatment of CMV retinitis in patients with acquired immunodeficiency syndrome (AIDS) and prevention of CMV disease in kidney, heart, and kidney-pancreas transplant patients at high risk.

According to IQVIA (IMS Health), Valcyte and its generic equivalents had US sales of approximately $79 million for the 12-month period ending September 2018.

Cipla is a global pharmaceutical company which uses cutting edge technology and innovation to meet the everyday needs of all patients. The company’s portfolio includes over 1500 products across wide range of therapeutic categories with one quality standard globally.

Cipla Share Price

1466.05 -0.10 (-0.01%)
12-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1736.85
Dr. Reddys Lab 1215.65
Cipla 1466.05
Zydus Lifesciences 895.00
Lupin 2189.75
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×